ES2194107T3 - Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales. - Google Patents

Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.

Info

Publication number
ES2194107T3
ES2194107T3 ES96922842T ES96922842T ES2194107T3 ES 2194107 T3 ES2194107 T3 ES 2194107T3 ES 96922842 T ES96922842 T ES 96922842T ES 96922842 T ES96922842 T ES 96922842T ES 2194107 T3 ES2194107 T3 ES 2194107T3
Authority
ES
Spain
Prior art keywords
pharmaceutical
treatment
profilaxis
gastrointestinal disorders
dietetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96922842T
Other languages
English (en)
Inventor
Haen Christoph De
Luigia Gozzini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco SpA
Original Assignee
Bracco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco SpA filed Critical Bracco SpA
Application granted granted Critical
Publication of ES2194107T3 publication Critical patent/ES2194107T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

LA INVENCION ACTUAL SE REFIERE A FORMULACIONES FARMACEUTICAS Y DIETETICAS PARA LA PROFILAXIS Y TRATAMIENTO DE LOS TRASTORNOS GASTROINTESTINALES.
ES96922842T 1995-06-23 1996-06-19 Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales. Expired - Lifetime ES2194107T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali

Publications (1)

Publication Number Publication Date
ES2194107T3 true ES2194107T3 (es) 2003-11-16

Family

ID=11371866

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96922842T Expired - Lifetime ES2194107T3 (es) 1995-06-23 1996-06-19 Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.

Country Status (18)

Country Link
US (1) US6007808A (es)
EP (1) EP0833644B1 (es)
JP (1) JPH11507934A (es)
CN (1) CN1082373C (es)
AT (1) ATE234623T1 (es)
AU (1) AU707399B2 (es)
BR (1) BR9609413A (es)
CA (1) CA2219739A1 (es)
DE (2) DE833644T1 (es)
DK (1) DK0833644T3 (es)
ES (1) ES2194107T3 (es)
HU (1) HUP9901707A3 (es)
IT (1) IT1276783B1 (es)
MX (1) MX9709238A (es)
NO (1) NO976048L (es)
NZ (1) NZ312121A (es)
WO (1) WO1997000688A1 (es)
ZA (1) ZA965235B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
CA2407724A1 (en) * 2000-05-03 2001-11-08 University Of Maryland, Baltimore Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
ATE421990T1 (de) * 2002-07-22 2009-02-15 Meito Sangyo Kk Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
ES2607988T3 (es) * 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
BRPI0611493B1 (pt) * 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
WO2007119502A1 (ja) * 2006-03-23 2007-10-25 Kyowa Hakko Kogyo Co., Ltd. 便通改善剤
JP5264702B2 (ja) * 2006-03-29 2013-08-14 ネステク ソシエテ アノニム プロバイオティクスを含有する栄養補助食品
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
US20120087902A1 (en) 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9856451B2 (en) 2011-12-28 2018-01-02 Yamada Bee Company Inc. Lactic acid bacterium having IgA production promoting activity, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5397803A (en) * 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) * 1989-08-05 1991-03-22 Mitsubishi Motors Corp エンジンの吸入空気量制御装置
CN1105544A (zh) * 1994-09-09 1995-07-26 扬州大学农学院 一种制取活性乳酸菌口服液的方法
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding

Also Published As

Publication number Publication date
CN1188413A (zh) 1998-07-22
EP0833644A1 (en) 1998-04-08
ITMI951359A1 (it) 1996-12-23
NO976048L (no) 1998-02-23
US6007808A (en) 1999-12-28
DE833644T1 (de) 1998-09-03
DK0833644T3 (da) 2003-07-21
ZA965235B (en) 1997-01-09
MX9709238A (es) 1998-03-31
JPH11507934A (ja) 1999-07-13
DE69626818D1 (de) 2003-04-24
CA2219739A1 (en) 1997-01-09
HUP9901707A2 (hu) 1999-09-28
BR9609413A (pt) 1999-05-18
ATE234623T1 (de) 2003-04-15
AU707399B2 (en) 1999-07-08
WO1997000688A1 (en) 1997-01-09
AU6357596A (en) 1997-01-22
DE69626818T2 (de) 2003-11-20
NZ312121A (en) 1999-03-29
HUP9901707A3 (en) 2001-04-28
EP0833644B1 (en) 2003-03-19
CN1082373C (zh) 2002-04-10
NO976048D0 (no) 1997-12-22
IT1276783B1 (it) 1997-11-03
ITMI951359A0 (it) 1995-06-23

Similar Documents

Publication Publication Date Title
ES2194107T3 (es) Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.
EE03472B1 (et) Ravimvormid inimese seksuaalreaktsiooni moduleerimiseks
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
BR9603676A (pt) Prótese para perna
HN1997000052A (es) Nuevas 4(3h)--quinazolinas 2,3-disustituidas
BR9610153A (pt) Formulações farmacêuticas
PT1254899E (pt) Derivados de piperazina e sua utilizacao como agentes anti-inflamatorios
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
BR9106864A (pt) Composicoes de liberacao prolongada para o tratamento de doencas periodontais
BR9712491A (pt) Composições cosméticas
PT971717E (pt) Amino-acucar citotoxico e derivados de acucar afins de indolopirrolocarbazois
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2036259T3 (es) Un procedimientos para la preparacion de agentes antiinflamatorios.
ES2192704T3 (es) Innovadoras composiciones farmaceuticas.
ES2162110T3 (es) Derivados de la quinolina antimalaria.
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
MX9601994A (es) Profarmacos de derivados de paclitaxel.
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
FR2686503B1 (fr) Prothese de rehabilitation de la tete femorale.
IT1299264B1 (it) Composizioni farmaceutiche topiche utili per il trattamento di patologie cutanee su base infiammatoria, immunitaria o proliferativa
ATE28188T1 (de) Antikonvulsive mittel.